Brivaracetam (All indications) updated on 04-22-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)5.11 [0.60, 43.25]0%2 studies12517not evaluable ROB-
Major congenital malformations5.11 [0.60, 43.25]0%2 studies12517not evaluable ROB-